Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles ...

Akeso's immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug ...

Lizzi C. Lee speaks with Gary Rieschel about what's behind China's biotech boom, potential risks, and long-term global ...

Last year, Summit Therapeutics ( SMMT 1.31%) was one of the stars of the biotech industry. The company's shares soared ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...

China issued the final version of its compliance guidelines for health care companies to prevent commercial bribery ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

Our Bureau, Mumbai Thursday, March 20, 2025, 09:00 Hrs [IST] CPHI & PMEC China, Asia's premier pharmaceutical event for sour ...

Legend Biotech (NASDAQ:LEGN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $82.00 to ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries to ...